Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials
Completed · Not applicable
Conditions studied: Malignant Neoplasm
In brief
This randomized clinical trial compares multimedia psychoeducation to print education in preparing patients with cancer for decision making about clinical trial participation. Multimedia psychoeducation includes a digital video disc (DVD) and written materials with a combined focus on knowledge and attitude change, and may be an effective method to help patients prepare for decision making about clinical trial participation. It is not yet known whether a multimedia psychoeducation is more effective than print education in preparing patients for decision making about clinical trials.
Key facts
- Study ID
- NCT02054715
- Run by
- Gary Morrow
- People needed
- 418
- Starts
- 2014-05-01
- Expected to finish
- 2016-11-01
- Last updated by the study team
- 2021-01-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Be able to speak and read English
- Be diagnosed with cancer
- Have been informed of their eligibility for a specific phase II or III therapeutic clinical trial open for enrollment at the participating NCI Community Oncology Research Program (NCORP) site
- Have already met one or more eligibility criteria and have a reasonable expectation of meeting any remaining eligibility criteria for the therapeutic clinical trial
- Be capable of providing written informed consent for study participation
You may not qualify if…
- Participants must not have been asked previously to participate in another therapeutic cancer clinical trial
- Participants must not have already made a decision to participate in the phase II or III therapeutic clinical trial for which they were informed of their eligibility
- Participants must not have documented or observable visual, auditory, psychiatric, or neurological disorders that would interfere with study participation (e.g., blindness, deafness, psychosis, or dementia)
- Participants must not be eligible only for phase I trial; these patients are excluded because few of these trials are offered at NCORP sites and because their design and goals differ considerably from those of phase II and III trials
Where it is running
- San Diego State University — San Diego, California, United States
- H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- Hawaii MU-NCORP — Honolulu, Hawaii, United States
- Heartland NCORP — Decatur, Illinois, United States
- Kansas City Clinical Oncology Program — Prairie Village, Kansas, United States
- Gulf South MU-NCORP — New Orleans, Louisiana, United States
- Cancer Research Consortium of West Michigan — Grand Rapids, Michigan, United States
- Metro MN NCORP — Minneapolis, Minnesota, United States
- Nevada Cancer Research Foundation NCORP — Las Vegas, Nevada, United States
- Nevada NCORP — Las Vegas, Nevada, United States
- URCC / University of Rochester NCORP Research Base — Rochester, New York, United States
- Southeast Clinical Oncology Research Consortium — Winston-Salem, North Carolina, United States
- Columbus NCORP — Columbus, Ohio, United States
- Dayton Community Oncology Program — Dayton, Ohio, United States
- Geisinger Cancer Institute NCORP — Danville, Pennsylvania, United States
- Greenville Health System Cancer Instutite/Greenville NCORP — Greenville, South Carolina, United States
- Wisconsin NCORP — Marshfield, Wisconsin, United States
- Aurora NCORP — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.